Sepul Bio is developing Sepofarsen and Ultevursen for debilitating genetic eye diseases such as LCA10 and Usher2a. Sepul Bio is dedicated to innovation and the advancement of therapies in the hope of providing treatment options for rare genetic eye diseases.
A Vision for the Future
Our projects are driven by the vision of a future where patients with inherited eye diseases have treatment options for their eye condition. Through ongoing research and rigorous development, Sepul Bio hopes to bring new therapies to patients.